Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Can J Psychiatry

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    February 2018
  1. BAHJI A, Bajaj N
    Gaps in Psychiatric Training Could Challenge Delivery of Optimal Schizophrenia Pharmacotherapy.
    Can J Psychiatry. 2018;63:146-147.
    PubMed     Text format    


    December 2017
  2. CHEN S, Collins A, Anderson K, McKenzie K, et al
    Patient Characteristics, Length of Stay, and Functional Improvement for Schizophrenia Spectrum Disorders: A Population Study of Inpatient Care in Ontario 2005 to 2015.
    Can J Psychiatry. 2017;62:854-863.
    PubMed     Text format     Abstract available


    September 2017
  3. CROCKFORD D, Addington D
    Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.
    Can J Psychiatry. 2017;62:624-634.
    PubMed     Text format     Abstract available


  4. LECOMTE T, Abidi S, Garcia-Ortega I, Mian I, et al
    Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Children and Youth.
    Can J Psychiatry. 2017;62:648-655.
    PubMed     Text format     Abstract available


  5. ADDINGTON D, Anderson E, Kelly M, Lesage A, et al
    Canadian Practice Guidelines for Comprehensive Community Treatment for Schizophrenia and Schizophrenia Spectrum Disorders.
    Can J Psychiatry. 2017;62:662-672.
    PubMed     Text format     Abstract available


    April 2017
  6. ANDERSON KK, Kurdyak P
    Factors Associated with Timely Physician Follow-up after a First Diagnosis of Psychotic Disorder.
    Can J Psychiatry. 2017;62:268-277.
    PubMed     Text format     Abstract available


  7. GAL G, Munitz H, Levav I
    Health Care and Mortality among Persons with Severe Mental Illness.
    Can J Psychiatry. 2017;62:259-267.
    PubMed     Text format     Abstract available


    February 2017
  8. MULLER-ISBERNER R
    The Use of Scientific Evidence about Schizophrenia and Violence in Clinical Services.
    Can J Psychiatry. 2017;62:84-85.
    PubMed     Text format    


  9. VASUDEV K, Choi YH, Norman R, Kim RB, et al
    Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Can J Psychiatry. 2017;62:138-149.
    PubMed     Text format     Abstract available


    January 2017
  10. BAUMANN PS, Elowe J, Mebdouhi N, Solida A, et al
    [Case Formulation in Early Psychosis: What are the Tools for Teamwork?]
    Can J Psychiatry. 2017 Jan 1:706743717703641. doi: 10.1177/0706743717703641.
    PubMed     Text format    


  11. MUNOZ-NEGRO JE, Ibanez-Casas I, de Portugal E, Lozano-Gutierrez V, et al
    A Psychopathological Comparison between Delusional Disorder and Schizophrenia.
    Can J Psychiatry. 2017 Jan 1:706743717706347. doi: 10.1177/0706743717706347.
    PubMed     Text format     Abstract available


  12. SISKIND D, Siskind V, Kisely S
    Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis.
    Can J Psychiatry. 2017 Jan 1:706743717718167. doi: 10.1177/0706743717718167.
    PubMed     Text format     Abstract available


  13. VALERIE M, Julie P, Luis A, M-Mehdi G, et al
    [Insight and Violent Behavior in a Cohort of Early Psychosis Patients].
    Can J Psychiatry. 2017 Jan 1:706743717718173. doi: 10.1177/0706743717718173.
    PubMed     Text format    


  14. STIP E, Caron J, Tousignant M, Lecomte Y, et al
    Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition.
    Can J Psychiatry. 2017 Jan 1:706743717715207. doi: 10.1177/0706743717715207.
    PubMed     Text format     Abstract available


  15. NORMAN R, Lecomte T, Addington D, Anderson E, et al
    CPA Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults.
    Can J Psychiatry. 2017 Jan 1:706743717719894. doi: 10.1177/0706743717719894.
    PubMed     Text format     Abstract available


  16. REMINGTON G, Addington D, Honer W, Ismail Z, et al
    Guidelines for the Pharmacotherapy of Schizophrenia in Adults.
    Can J Psychiatry. 2017 Jan 1:706743717720448. doi: 10.1177/0706743717720448.
    PubMed     Text format     Abstract available


  17. PRINGSHEIM T, Kelly M, Urness D, Teehan M, et al
    Physical Health and Drug Safety in Individuals with Schizophrenia.
    Can J Psychiatry. 2017 Jan 1:706743717719898. doi: 10.1177/0706743717719898.
    PubMed     Text format     Abstract available


  18. ADDINGTON J, Addington D, Abidi S, Raedler T, et al
    CPA Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.
    Can J Psychiatry. 2017 Jan 1:706743717719895. doi: 10.1177/0706743717719895.
    PubMed     Text format     Abstract available


  19. ADDINGTON D, Abidi S, Garcia-Ortega I, Honer WG, et al
    Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders.
    Can J Psychiatry. 2017 Jan 1:706743717719899. doi: 10.1177/0706743717719899.
    PubMed     Text format     Abstract available


  20. ABIDI S, Mian I, Garcia-Ortega I, Lecomte T, et al
    CPA Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.
    Can J Psychiatry. 2017 Jan 1:706743717720197. doi: 10.1177/0706743717720197.
    PubMed     Text format     Abstract available


  21. PRINGSHEIM T, Addington D
    Canadian Schizophrenia Guidelines: Introduction and Guideline Development Process.
    Can J Psychiatry. 2017 Jan 1:706743717719897. doi: 10.1177/0706743717719897.
    PubMed     Text format     Abstract available


  22. KIM HS, Cassetta BD, Hodgins DC, Tomfohr-Madsen LM, et al
    Assessing the Relationship between Disordered Gamblers with Psychosis and Increased Gambling Severity: The Mediating Role of Impulsivity.
    Can J Psychiatry. 2017 Jan 1:706743717730825. doi: 10.1177/0706743717730825.
    PubMed     Text format     Abstract available


  23. KAO YC, Lien YJ, Chang HA, Tzeng NS, et al
    Stigma Resistance in Stable Schizophrenia: The Relative Contributions of Stereotype Endorsement, Self-Reflection, Self-Esteem, and Coping Styles.
    Can J Psychiatry. 2017 Jan 1:706743717730827. doi: 10.1177/0706743717730827.
    PubMed     Text format     Abstract available


  24. NAVARRA-VENTURA G, Fernandez-Gonzalo S, Turon M, Pousa E, et al
    Gender Differences in Social Cognition: A Cross-Sectional Pilot Study of Recently Diagnosed Patients with Schizophrenia and Healthy Subjects.
    Can J Psychiatry. 2017 Jan 1:706743717746661. doi: 10.1177/0706743717746661.
    PubMed     Text format     Abstract available


    September 2016
  25. HODGINS S, Klein S
    New Clinically Relevant Findings about Violence by People with Schizophrenia.
    Can J Psychiatry. 2016 Sep 7. pii: 0706743716648300.
    PubMed     Text format     Abstract available


    August 2016
  26. JACOBS P
    Cost-Effectiveness Results for Early Psychosis Intervention Programs Are Influenced by the Perspective Taken.
    Can J Psychiatry. 2016;61:470.
    PubMed     Text format    


  27. BERGMAN O, Ben-Shachar D
    Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.
    Can J Psychiatry. 2016;61:457-69.
    PubMed     Text format     Abstract available


    June 2016
  28. QUINN J, Kolla NJ
    From Clozapine to Cognitive Remediation: A Review of Biological and Psychosocial Treatments for Violence in Schizophrenia.
    Can J Psychiatry. 2016 Jun 22. pii: 0706743716656830.
    PubMed     Text format     Abstract available


  29. AYDIN C, Tibbo PG, Ursuliak Z
    Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.
    Can J Psychiatry. 2016;61:367-372.
    PubMed     Text format     Abstract available


    May 2016
  30. WILLIAMS R, Malla A, Roy MA, Joober R, et al
    What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?
    Can J Psychiatry. 2016 May 18. pii: 0706743716651049.
    PubMed     Text format     Abstract available


  31. MACHADO AK, Pan AY, da Silva TM, Duong A, et al
    Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar Disorder.
    Can J Psychiatry. 2016 May 9. pii: 0706743716648297.
    PubMed     Text format     Abstract available


  32. DUFFY A, Malhi GS, Grof P
    Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?
    Can J Psychiatry. 2016 May 4. pii: 0706743716649189.
    PubMed     Text format     Abstract available


  33. LAWFORD BR, Barnes M, Morris CP, Noble EP, et al
    Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.
    Can J Psychiatry. 2016;61:291-297.
    PubMed     Text format     Abstract available


    March 2016
  34. DEWA CS, Trojanowski L, Cheng C, Hoch JS, et al
    Potential Effects of the Choice of Costing Perspective on Cost Estimates: An Example Based on 6 Early Psychosis Intervention Programs.
    Can J Psychiatry. 2016 Mar 17. pii: 0706743716639917.
    PubMed     Text format     Abstract available


  35. NOLIN M, Malla A, Tibbo P, Norman R, et al
    Early Intervention for Psychosis in Canada: What Is the State of Affairs?
    Can J Psychiatry. 2016;61:186-194.
    PubMed     Text format     Abstract available


    November 2015
  36. LEE J, Takeuchi H, Fervaha G, Sin GL, et al
    Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.
    Can J Psychiatry. 2015;60:515-522.
    PubMed     Text format     Abstract available


  37. AGID O, Mcdonald K, Fervaha G, Littrell R, et al
    Values in First-Episode Schizophrenia.
    Can J Psychiatry. 2015;60:507-514.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: